US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,487.45

+26.261.80%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,489.14

Open:1,460.44

Low:1,460.44

Close:1,461.02

Loading ...

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires Live

Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute

Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%

Amgen (NASDAQ:AMGN) Enters Late-Stage Testing on Weight Loss Drug

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

Simply Wall St.

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Associated Press Finance

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court

MT Newswires Live

Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials

Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide

MT Newswires Live

German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports

Novo Nordisk launches $499 Wegovy cash option and home delivery

Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock -- Barrons.com

Why Novo Nordisk (NVO) Is Rising Today

Novo Nordisk Launches NovoCare Pharmacy to Ship Wegovy Doses to Users' Homes

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1487.2886,"timestamp":1741202986603,"preClose":1461.0245,"halted":0,"volume":35336927,"delay":0,"changeRate":0.017976,"change":26.264038,"pbRate":11.821485,"amount":2953715316.932554,"amplitude":0.019638,"prevYearClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"turnoverRate":0.003348,"marketCap":1601215973376,"floatMarketCap":1485035087872,"peRate":42.075031},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1489.1365,"amplitude":0.019638,"preClose":1461.0245,"low":1460.4442,"pbRate":"11.821485","latestPrice":1487.4546,"volume":35332004,"delay":0,"open":1460.4442,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"sixtyDayClose":1441.3252,"secType":"PLATE","market":"US","turnoverRate":0.003347,"peRate":42.075031,"marketCap":1601374388864,"floatMarketCap":1485192659840,"timestamp":1741202982052,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517928707","title":"Sector Update: Health Care Stocks Higher in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517928707?lang=en_us&edition=fundamental","pubTime":"2025-03-06 02:54","pubTimestamp":1741200858,"startTime":"0","endTime":"0","summary":"Health care stocks were rising Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each adding 0.6%.The iShares Biotechnology ETF  added 1.1%.In corporate news, Novo Nordisk  said it launched a direct-to-patient delivery option that offers patients all dose strengths of Wegovy at a reduced cost. Novo shares gained 3.4%.Amgen  has started two phase 3 trials for its obesity drug MariTide, the company's Head of Research and Development, Jay Bradner, said Wednesday at an investor conference. Amgen shares rose 1.4%.Merck  is facing a patent dispute that threatens its plans to sell a new version of Keytruda, its top-selling cancer drug, the Wall Street Journal reported. Merck shares were fractionally higher.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","XLV","LU2112291526.USD","LU1934455277.USD","SG9999014542.SGD","LU0154236417.USD","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","BK4581","LU0868494617.USD","LU0289739699.SGD","LU0889565916.HKD","BK4559","LU0320765992.SGD","SG9999015341.SGD","LU1571399168.USD","LU1989772923.USD","MRK","LU2089984988.USD","LU1699723380.USD","LU0006306889.USD","LU0965509010.AUD","LU1162221912.USD","LU2461242641.AUD","BK4599","IE00BLSP4239.USD","SGXZ57979304.SGD","LU0320765646.SGD","LU2361044949.HKD","LU0109394709.USD","LU1116320737.USD","SG9999014559.SGD","SG9999002232.USD","LU0965508806.USD","BK4588","IE00B2B36J28.USD","IE00BKVL7J92.USD","NVO.AU","IE00BZ1G4Q59.USD","LU1057294990.SGD","AMGN","IE0002141913.USD","LU1066051498.USD","IBB","LU1037948541.HKD","LU1066053197.SGD","LU1093756325.SGD","NVO","BK4534","LU1430594728.SGD"],"gpt_icon":1},{"id":"2517694077","title":"Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2517694077","media":"GuruFocus.com","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517694077?lang=en_us&edition=fundamental","pubTime":"2025-03-06 02:05","pubTimestamp":1741197924,"startTime":"0","endTime":"0","summary":"March 5 - MODERNA  secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer  and BioNTech . A Dusseldorf court ruled in favor of Moderna, according to a Wednesday court filing.GuruFocus has detected 4 Warning Signs with MRNA.The court ruled that Pfizer and BioNTech must disclose any revenue gained from Moderna's patented technology, although the amount remains to be determined, and that they will pay extra.Pfizer and BioNTech exercised legal authorization to use their patent until May 2023. The court made a decision that Moderna legally withdrew their consent in March 2022 so their previous patent permission became void. Legal analysts view the court decision as a major advancement within pharmaceutical intellectual property rights that affects the industry.Industry stakeholders and investors now watch closely for further updates in this high-stakes patent conflict.This article first appeared on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/moderna-scores-legal-victory-over-180524255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","IE0002270589.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4534","MRNA","LU0122379950.USD","LU1894683264.USD","BK4592","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","LU0868494617.USD","LU1066053197.SGD","SG9999013999.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","SG9999002232.USD","LU0321505439.SGD","SG9999001176.SGD","BK4007","IE00B19Z3581.USD","LU0306806265.USD","LU1066051498.USD","LU0321505868.SGD","BK4585","LU1883839398.USD","LU0170899867.USD","BNTX","LU0225284248.USD","LU0306807586.USD","BK4581","IE00B19Z3B42.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","BK4568","LU0058720904.USD","SGXZ57979304.SGD","SG9999001176.USD","LU0225771236.USD","LU0456855351.SGD","PFE","BK4533","BK4599","LU0985481810.HKD","LU0234572021.USD"],"gpt_icon":1},{"id":"2517392885","title":"Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517392885","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517392885?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:59","pubTimestamp":1741197573,"startTime":"0","endTime":"0","summary":"Novo Nordisk  shares rallied 4% Wednesday morning after the drug maker cut the price of its popular weight-loss drug, Wegovy, by more than 50%. The company now offers all doses of Wegovy for $499 per month, down from a previous price of $1,349 for a 28-day supply. In tandem, Novo Nordisk launched NovoCare Pharmacy, an online platform that delivers the FDA-approved drug directly to patients' homes.GuruFocus has detected 1 Warning Sign with NVO.The pricing shift and digital rollout intensified competitive pressures, prompting shares of rival Hims & Hers  to slide. Hims & Hers markets lower-cost compounds containing the same active ingredient as Wegovy, putting it at a disadvantage in the expanding weight-loss market.Dave Moore, Executive Vice President of U.S. Operations and Global Business Development, said NovoCare Pharmacy offers a convenient alternative for cash-paying patients while upholding the company's high-quality standards. Investors will monitor how these strategic moves affe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-shares-climb-wegovy-175933079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKVL7J92.USD","BK4599","BK4588","LU1093756325.SGD","NVO","LU0154236417.USD","LU1093756168.USD","BK4007","BK4532","BK4585","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2517947696","title":"Amgen (NASDAQ:AMGN) Enters Late-Stage Testing on Weight Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947696","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517947696?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:34","pubTimestamp":1741196086,"startTime":"0","endTime":"0","summary":"We know that weight loss drugs have been big winners for the companies that produce them. And now, biotech stock Amgen ($AMGN) looks to get in on t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/amgen-nasdaqamgn-enters-late-stage-testing-on-weight-loss-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/amgen-nasdaqamgn-enters-late-stage-testing-on-weight-loss-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","BK4581","BK4588","IE00B3QW5Z07.USD","LU0109394709.USD","BK4533","LU0868494617.USD","TQQQ","IE00BJT1NW94.SGD","LU0058720904.USD","MNQmain","IE0002141913.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00B64PRP62.GBP","LU2242646821.SGD","LU2242652126.USD","LU2210150020.SGD","NQmain","IE00BGHQF748.EUR","BK4566","USAW.SI","LU1061106388.HKD","LU0320765992.SGD","TSYW.SI","IE00B4R5TH58.HKD","AMGN","QID","LU0889565916.HKD","LU2095319765.USD","SG9999001440.SGD","LU1023059063.AUD","LU0122379950.USD","LU1057294990.SGD","LU1571399168.USD","BK4599","LU1983299246.USD","NDAQ","IE00B2B36J28.USD","BK4139","SQQQ","BK4112",".IXIC","IE0009355771.USD","LU2210149790.SGD","QLD","USJW.SI","NVIW.SI","PSQ"],"gpt_icon":0},{"id":"2517947648","title":"Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947648","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517947648?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:15","pubTimestamp":1741194907,"startTime":"0","endTime":"0","summary":"Amgen's recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and perhaps aided in boosting its shares by 12% over the last quarter. The company's financial performance, highlighted by a revenue increase for 2024 despite a decrease in net income, indicates resilience. Concurrently, their product developments, such as the positive Phase III results for TEZSPIRE and FDA approval for LUMAKRAS, signal strong therapeutic advancements. The announcement of Amgen’s $1 billion expansion in North Carolina and their pursuit of acquisitions underscore their growth ambitions. While broader market conditions saw volatility, Amgen's strategic progress and shareholder returns appear to resonate with investors. As the market wavered amid tariff uncertainties and mixed economic signals, Amgen's focus on robust dividends and corporate growth initiatives likely played a key role in driving their stock performance.NasdaqGS:AMGN Earnings Per Share Growth as at Mar 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-declares-us-171507864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0868494617.USD","BK4566","IE0002141913.USD","SG9999001440.SGD","LU0289739699.SGD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0058720904.USD","LU0109394709.USD","AMGN","LU0320765992.SGD","LU2242652126.USD","BK4588","LU1983299246.USD","LU2242646821.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","BK4599","LU1023059063.AUD","LU0889565916.HKD","LU0122379950.USD","BK4139","BK4534","LU1057294990.SGD","BK4533"],"gpt_icon":0},{"id":"2517424489","title":"Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2517424489","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517424489?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:59","pubTimestamp":1741193948,"startTime":"0","endTime":"0","summary":"Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Danish drugmaker Novo Nordisk  said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499, down from $650, takes effect immediately.Novo said the new pricing is available to both the uninsured and people who have insurance that doesn't cover the weight-loss drugs.Last week, Eli Lilly  said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.The price cuts come as supplies improve. The U.S. Food and Drug Administration has moved both drugs off its list of medicines in shortage. The agency has said compounding pharmacies and other entities that have been allowed to make off-brand, cheaper copies of the drugs during the shortage will have to wind down production.The Associated Press Health and Science Department receives support ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-cuts-wegovy-prices-165908815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BK4W5M84.HKD","LU0823416689.USD","LU1917777945.USD","LU2237443978.SGD","NVO","LU0456855351.SGD","LU0354030511.USD","BK4007","BK4533","LU0466842654.USD","LU1057294990.SGD","SG9999017495.SGD","SG9999014906.USD","LU0096364046.USD","LU0203201768.USD","LU2237443465.HKD","LLY","LU0097036916.USD","LU0238689110.USD","BK4599","LU1804176565.USD","LU2023250504.SGD","LU0256863811.USD","LU1868837300.USD","LU0640476718.USD","SG9999015945.SGD","LU0058720904.USD","LU1023059063.AUD","BK4581","LU0106261372.USD","LU1623119135.USD","LU1868836757.USD","LU0154236417.USD","LU0122379950.USD","LU1366192091.USD","LU1035775433.USD","SGXZ99366536.SGD","SG9999014898.SGD","LU0256863902.USD","LU1974910355.USD","LU2324357040.USD","LU0006306889.USD","LU1093756325.SGD","BK4588","LU1720051017.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0882574139.USD","SGXZ57979304.SGD","SGXZ51526630.SGD"],"gpt_icon":1},{"id":"2517427369","title":"Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2517427369","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517427369?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:39","pubTimestamp":1741192775,"startTime":"0","endTime":"0","summary":"We recently published an article titled These 10 Stocks Defied Tuesday's Bloodbath.In this article, we are going to take a look at where Viking Therapeutics, Inc.  stands against the other stocks.The stock market fell further into negative territory on Tuesday as trade tensions between the US and its largest trading partners continued.The Dow Jones fell the most, losing 1.55 percent, while the S&P 500 declined 1.22 percent. The Nasdaq dropped by 0.35 percent.Viking Therapeutics, Inc.  grew its share prices by 9.30 percent on Tuesday to close at $28.09 apiece as investors gobbled up shares in the company in hopes that it would announce new developments in two investor conferences this month.In a statement, Viking Therapeutics, Inc.  said it would participate in Leerink Partners Global Health Conference on March 10 to 12, and in Jefferies Biotech on the Beach Summit from March 11 to 12, both in Miami, Florida.Latest reports about the company surfaced that pharmaceutical giant Pfizer Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-viking-therapeutics-inc-vktx-163935032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","MNQmain","NVIW.SI","BK4007",".IXIC","LU2347655156.SGD","LU0098860793.USD","LU1720051108.HKD","LU0306807586.USD","IE00BLSP4239.USD","LU2023251221.USD","PSQ","IE00B19Z3B42.SGD","BK4599","SQQQ","USJW.SI","LU0106261372.USD","LU0122379950.USD","BK4516","LU0985481810.HKD","QID","LU0106831901.USD","BK4581","SG9999003800.SGD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU2028103732.USD","BK4550","LU2089283258.USD","LU1057294990.SGD","LU0058720904.USD","BK4588","NQmain","LU2111349929.HKD","VKTX","LU1023059063.AUD","BK4534","USAW.SI","LU0321505868.SGD","LU0306806265.USD","IE0002270589.USD","BK4504","TSYW.SI","LU0868494617.USD","QLD","LU0795875086.SGD","IE00BKVL7J92.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2517941134","title":"Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941134","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517941134?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:28","pubTimestamp":1741192136,"startTime":"0","endTime":"0","summary":"Pfizer  and its partner BioNTech  have infringed a COVID-19 vaccine patent owned by Moderna , Reuters reported Wednesday, citing a German court ruling.The court reportedly ordered Pfizer and BioNTech to disclose earnings related to the patent's use and pay a compensation to Moderna, according to the report.Pfizer and BioNTech argued they were permitted to use the technology based on Moderna's public statement until the World Health Organization declared in May 2023 that COVID-19 was no longer a global emergency, the media outlet reported.The court did not determine the compensation amount, which will be decided in further legal proceedings and could change if there is an appeal, Reuters said.Pfizer, BioNTech and Moderna did not immediately respond to requests for comment from MT Newswires.Price: 25.87, Change: +0.12, Percent Change: +0.47","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PFE","SG9999002232.USD","SG9999001176.USD","BK4550","LU0225284248.USD","BK7095","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","LU1066051498.USD","BK4501","LU0234572021.USD","IE00BLSP4239.USD","BK4599","BNTX","SG9999011175.SGD","LU1894683348.USD","LU0321505439.SGD","BK4535","LU0225771236.USD","IE00B19Z3581.USD","LU0985481810.HKD","LU1023059063.AUD","SG9999001176.SGD","LU0868494617.USD","BK4592","LU0058720904.USD","BK4533","BK4581","BK4588","PFE.AU","LU0321505868.SGD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU0289739699.SGD","BK4534","BK4585","SG9999003800.SGD","IE00BLSP4452.SGD","LU0306806265.USD","LU1066053197.SGD","MRNA","BK4548","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4139","BK4568","LU1883839398.USD","LU0170899867.USD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2517941055","title":"Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517941055?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:26","pubTimestamp":1741191962,"startTime":"0","endTime":"0","summary":"Matt Phipps, an analyst from William Blair, has initiated a new Buy rating on Amgen (AMGN). Matt Phipps has given his Buy rating due to a combinati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/amgens-strategic-growth-potential-bolstered-by-promising-maritide-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/amgens-strategic-growth-potential-bolstered-by-promising-maritide-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","BK4599","BK4139","BK4566","AMGN","LU1983299246.USD","BK4534","LU0889565916.HKD","BK4533","BK4588","LU1057294990.SGD","III","LU1061106388.HKD","LU2242652126.USD","LU1023059063.AUD","BK4585","BK4134","LU0109394709.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1571399168.USD","SG9999001440.SGD","LU0320765992.SGD","LU0122379950.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0289739699.SGD","BK4581","IE0002141913.USD"],"gpt_icon":0},{"id":"2517510941","title":"Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide","url":"https://stock-news.laohu8.com/highlight/detail?id=2517510941","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517510941?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:25","pubTimestamp":1741191954,"startTime":"0","endTime":"0","summary":"Amgen  has initiated two phase 3 trials for its obesity drug MariTide, the company's Head of Research and Development, Jay Bradner, said Wednesday at an investor conference.One of the trials is in people with obesity or overweight without type 2 diabetes, and is expected to enroll 3,500 people, Bradner said. The second trial is in people with obesity or overweight who have type 2 diabetes, with Amgen intending to enroll 999 patients, he added.The studies will test different dose levels, starting at a lower dose. Bradner said the primary endpoint is the change in baseline body weight at 72 weeks.Price: 313.79, Change: +1.60, Percent Change: +0.51","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","AMGN","IE0009355771.USD","LU0122379950.USD","LU2112291526.USD","LU0868494617.USD","BK4139","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0289739699.SGD","LU2242646821.SGD","IE00B2B36J28.USD","BK4588","BK4566","BK4533","IE0002141913.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4599","LU0320765992.SGD","LU0058720904.USD","BK4534","LU1571399168.USD","BK4585","LU1983299246.USD","SG9999001440.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517194159","title":"German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194159","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517194159?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:21","pubTimestamp":1741191660,"startTime":"0","endTime":"0","summary":"-- A German court in Duesseldorf ruled that Pfizer and partner BioNTech broke a coronavirus vaccine patent held by Moderna, Reuters reports.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4599","LU1066053197.SGD","BK4533","PFE","BK4581","LU0985481810.HKD","LU1057294990.SGD","LU1894683348.USD","BK4592","LU1883839398.USD","IE00BLSP4452.SGD","SG9999001176.SGD","SG9999001176.USD","BK4585","BK4551","LU0321505868.SGD","SG9999003800.SGD","LU1023059063.AUD","LU0289739699.SGD","LU0058720904.USD","BK4532","IE00B19Z3581.USD","LU1066051498.USD","SG9999002232.USD","LU0868494617.USD","BNTX","SG9999002224.SGD","LU0234572021.USD","BK4007","BK4535","BK4550","LU0306806265.USD","SGXZ57979304.SGD","MRNA","BK4568","LU0321505439.SGD","BK4588","LU0122379950.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4501","BK4534","LU1894683264.USD","SG9999011175.SGD","LU0225771236.USD","SG9999013999.USD","BK4139","BK4548","LU0170899867.USD"],"gpt_icon":1},{"id":"2517949964","title":"Novo Nordisk launches $499 Wegovy cash option and home delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949964","media":"Yahoo Finance","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517949964?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:02","pubTimestamp":1741190548,"startTime":"0","endTime":"0","summary":"Novo Nordisk  announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery.The move follows competitor Eli Lilly , which similarly announced a $499 cash program for its weight-loss drug Zepbound.The two GLP-1 market leaders see the need to launch more access points to meet ongoing demand for the drugs. Especially after the FDA determined that their products, also known by their active ingredients — semaglutide for Wegovy and tirzepatide for Zepbound — are no longer in shortage, starting a countdown clock to unbranded knockoffs sold by compounding pharmacies.The new prices from both companies provide a 50% or more discount from the known list prices. Wegovy, for example, is listed for around $1,350 per month. but most patients pay less depending on their insurance coverage.Novo Nordisk's stock jumped more than 4% following the news Wednesday.Click here for in-depth analysis of the latest health industry news and events im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-launches-499-wegovy-cash-option-and-home-delivery-160228264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","LU2324357040.USD","LU1804176565.USD","BK4532","LU0096364046.USD","LU2237443622.USD","LU2063271972.USD","LU2089984988.USD","LU0456855351.SGD","LU2237438978.USD","LU0320765059.SGD","LU1057294990.SGD","IE00BJLML261.HKD","LU1064131342.USD","SG9999015986.USD","LU2468319806.SGD","LU1023059063.AUD","LU1291159041.SGD","LU1720051108.HKD","LU1988902786.USD","LU0708995401.HKD","LU2361045086.USD","LU1868836914.USD","LU0058720904.USD","LLY","LU1548497426.USD","IE0004445239.USD","LU0640476718.USD","LU0061475181.USD","LU0094547139.USD","SG9999017495.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2265009873.SGD","LU0385154629.USD","BK4516","LU0354030511.USD","NVO","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU1868836757.USD","SGXZ31699556.SGD","LU0154236417.USD","LU1974910355.USD","SG9999014880.SGD","BK4581","LU0943347566.SGD","LU1093756325.SGD","LU0203201768.USD"],"gpt_icon":1},{"id":"2517496009","title":"Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517496009?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:56","pubTimestamp":1741190160,"startTime":"0","endTime":"0","summary":"The drugmaker Novo Nordisk has landed a solid blow against Hims & Hers Health, as Novo looks to recapture the patients it lost to companies selling legal knockoff versions of its weight-loss drug Wegovy.Novo Nordisk said Wednesday it will sell Wegovy at lower prices to uninsured patients and to patients whose insurance doesn't cover the medicine, through its own online pharmacy.The announcement comes weeks after the Food and Drug Administration declared that Wegovy is no longer in shortage. That means Hims will have to stop selling its copycat version of Wegovy in the coming months, and will largely shift its weight-loss offerings to older generic pills.Hims sold $225 million worth of its Wegovy knockoff last year, and wants to parlay that into a durable weight-loss medicine business over the coming years.That raises the stakes as the shortages end, and patients begin to look for alternatives for the compounded versions on which they had been relying. If Novo Nordisk and Lilly can capt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","IE00B2B36J28.USD","LU0708995401.HKD","BK4007","BK4585","BK4599","LU1093756325.SGD","SG9999014880.SGD","HIMS","SGXZ57979304.SGD","LU0198837287.USD","SGXZ51526630.SGD","LU0354030511.USD","SG9999014914.USD","IE00BJT1NW94.SGD","LU0079474960.USD","LU0466842654.USD","LU0672654240.SGD","LU1868837136.USD","BK4533","LU1548497426.USD","NVO","SG9999018865.SGD","LU0256863811.USD","LU0114720955.EUR","LU0385154629.USD","LU1712237335.SGD","LU0096364046.USD","LU1868836914.USD","LU0320765059.SGD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU2360106947.USD","LU1623119135.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU2063271972.USD","LU1988902786.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU2211815571.USD","IE00BK4W5L77.USD","LU1023059063.AUD","LU2357305700.SGD","IE0009355771.USD","LU2361044865.SGD","IE00BKVL7J92.USD","BK4588","LU1035775433.USD"],"gpt_icon":1},{"id":"2517946605","title":"Why Novo Nordisk (NVO) Is Rising Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946605","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517946605?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:37","pubTimestamp":1741189062,"startTime":"0","endTime":"0","summary":"Novo Nordisk  is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over 50%. Additionally, the company launched a new online pharmacy from which the drug can be obtained.The news caused Hims & Hers  to sink 9%. HIMS sells lower-cost compounds that incorporate the same active ingredient as Wegovy.Novo Nordisk announced that it planned to start selling all doses of Wegovy for $499 per month, versus the current list price of $1,349 for a 28-day supply.The firm also noted that it had started NovoCare Pharmacy which it called \"a direct-to-patient delivery option that offers cash-paying patients all dose strengths of Wegovy.\". \"With NovoCarePharmacy, patients and prescribers alike have another option that provides convenient access to all doses of real, FDA-approved Wegovy at a reduced cost in our high-quality pen,\" Dave Moore, Executive Vice President, U.S. Operations and Global Business Development and President of Novo Nordisk said in a state","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-novo-nordisk-nvo-rising-153742453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","BK4588","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","BK4007","LU1093756168.USD","BK4196","BK4532"],"gpt_icon":1},{"id":"2517948007","title":"Novo Nordisk Launches NovoCare Pharmacy to Ship Wegovy Doses to Users' Homes","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948007","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517948007?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:57","pubTimestamp":1741186620,"startTime":"0","endTime":"0","summary":"Novo Nordisk launched NovoCare Pharmacy, to deliver doses of its weight-loss Wegovy drug directly to its users, in a bid to reduce its cost.The Danish pharmaceutical company said Wednesday that the new direct-to-patient delivery option will allow Wegovy users to receive all dose strengths of the drug at a reduced cost of $499 per month.Uninsured patients and those with insurance that doesn't cover obesity drugs would also be able to make use of this offer, the group said.NovoCare Pharmacy arrives at a time of increased competition in the booming market for weight-loss drugs, still led by Eli Lilly and Novo Nordisk, which nonetheless are seeing smaller rivals such as Roche, Pfizer and Amgen striving to challenge them.The announcement comes a couple of weeks after the U.S. Food and Drug Administration declared that the shortage of Novo Nordisk's blockbuster GLP-1 drugs, Wegovy and Ozempic, had been resolved.All dose strengths of Wegovy are either meeting or surpassing current and project","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4599","LU1066053197.SGD","BK4533","BK4581","LU0985481810.HKD","LU1057294990.SGD","LU1894683348.USD","BK4592","LU1883839398.USD","IE00BZ1G4Q59.USD","SG9999001176.SGD","SG9999001176.USD","BK4585","LU1093756168.USD","SG9999003800.SGD","LU1023059063.AUD","LU0289739699.SGD","LU1093756325.SGD","IE0002270589.USD","LU0058720904.USD","BK4532","LU0154236417.USD","IE00B19Z3581.USD","LU0225284248.USD","IE000M9KFDE8.USD","LU1066051498.USD","SG9999002232.USD","LU0306807586.USD","LU0868494617.USD","LU0234572021.USD","BK4007","BK4550","IE00BLSP4239.USD","LU0306806265.USD","SGXZ57979304.SGD","BK4568","LU0321505439.SGD","BK4588","LU0122379950.USD","IE00B19Z3B42.SGD","BK4534","LU1894683264.USD","SG9999011175.SGD","LU0225771236.USD","SG9999013999.USD","IE00BKVL7J92.USD","LU0170899867.USD","NVO"],"gpt_icon":1},{"id":"2517945267","title":"Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945267","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517945267?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:51","pubTimestamp":1741186306,"startTime":"0","endTime":"0","summary":"Novo Nordisk slashed the price of Wegovy by more than half on Wednesday amid a bitter rivalry with Hims & Hers Health.","market":"fut","thumbnail":"https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novo-nordisk-wegovy-price-cut-hims-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1093756325.SGD","BK4585","BK4599","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","HIMS","NVO","BK4196","NVO.AU","BK7104","BK4007","BK4588","BK4532"],"gpt_icon":1}],"pageSize":16,"totalPage":14,"pageCount":1,"totalSize":212}]}}